Cholesterol is one of the major components of biological membranes and has an important function in osteoclast formation and survival. It has been reported that high-density lipoprotein (HDL) promotes cholesterol efflux from osteoclasts and induces their apoptosis, but the underlying mechanisms are unclear. In this study, we investigated how HDL promotes osteoclast cholesterol efflux and explored its effect on osteoclast formation and survival. Our results showed that the maximum diameter and fusion index of osteoclasts were decreased, while the ratios of osteoclasts with pyknotic nuclei were increased when cells were treated with HDL (600 ng/ml), as revealed by tartrate-resistant acid phosphatase-positive staining and microscopy assay. HDL enhanced cellular cholesterol efflux from osteoclasts in both concentration-and time-dependent manners. The ability of HDL3 to stimulate cholesterol efflux was stronger than preβ-HDL, HDL2, and ApoAI. Knockdown of ABCG1 expression reduced HDL-mediated cholesterol efflux and restored the HDLinduced reduction in osteoclast formation. Finally, HDL3 promoted sphingomyelin efflux from osteoclasts and reduced the expression of caveolin-1. Together, the findings demonstrate that HDL3 upregulates ABCG1 expression and promotes cholesterol efflux from osteoclast, impairs cholesterol homeostasis in osteoclasts, and consequently enhances osteoclast apoptosis.
Introduction
Cardiovascular disease (CVD) and osteoporosis are believed to be the two most common diseases in elderly people [1, 2] . Several epidemiological studies have revealed a positive correlation between the two diseases, suggesting a similar underlying mechanism for their pathogenesis [3] [4] [5] [6] . For instance, serum lipid level plays an important role in the pathogenesis of CVD [7] [8] [9] . It has also been reported that the treatment of CVD patients with statins, the lipid-lowering drugs, is associated with a significantly decreased fracture risk and increased bone mineral density [10] . Moreover, the low level of plasma highdensity lipoprotein cholesterol (HDL-C) has been shown to be associated with osteoporosis [11] . However, the mechanism underlying this potential association is unclear. It has been reported that HDL can reduce oxidized low-density lipoprotein (ox-LDL)-induced apoptosis of osteoblasts [12] , promote osteoclast cholesterol outflow, and induce osteoclast apoptosis [13] , indicating a close relationship of HDL with osteoporosis and an important role of HDL in bone metabolism. The mechanism of the impact of HDL-promoted osteoclast cholesterol efflux on osteoclast formation, however, has yet to be determined.
Osteoclasts are multinucleated cells derived from mononuclear precursor cells of the monocyte macrophage lineage and are responsible for aged bone reabsorption and new bone formation [14] . When the balance is disturbed, the architecture or function of bone is deregulated [13, 15] , which leads to osteoporosis or osteopetrosis. A variety of signal molecules and functional proteins are located in or associated with the plasma membrane, playing a crucial role in osteoclast cell membrane. For instance, the receptor activator of NF-κB (RANK)/RANK ligand (RANKL) activator of NF-κB (RANK)/ RANK ligand (RANKL) signal pathway and macrophage colonystimulating factor (M-CSF) play an important role in osteoclast differentiation, including multinucleation and formation [16, 17] . Cholesterol is a major structural and functional component of plasma membrane. Cyclodextrin enhances cholesterol efflux from osteoclasts and promotes apoptosis [14] .
The expression of hydroxymethylglutaryl coenzyme-A reductase in osteoclasts is very low [18] and cannot be regulated by cyclodextrin [19] , suggesting the lack of feedback regulation of the cholesterol biosynthesis pathway in osteoclasts. This indicates the inability of osteoclasts to synthesize cholesterol and emphasizes the significance of intracellular cholesterol balance in osteoclast cell formation, function, and survival.
HDL has three subfractions, preβ-HDL, HDL2, and HDL3 that are mainly composed of apolipoprotein AI (ApoAI), cholesteryl esters, and phospholipids, respectively [20] . It has been shown that HDL increases the efflux of intracellular cholesterol and plays a key role in reverse cholesterol transport (RCT) which is the process of cholesterol movement from the extrahepatic tissues back to the liver [21] . The roles of ATP-binding cassette transporter A1 (ABCA1) and ABCG1 in cholesterol efflux have been intensively studied in macrophages [22] . ABCA1 mainly mediates cholesterol efflux onto lipid-poor ApoAI. Considering that osteoclasts, like macrophages, are derived from mononuclear precursor cells and that low level of plasma HDL-C is associated with osteoporosis [22] , it is very important to understand the role of ABCG1 in cholesterol homeostasis in osteoclasts. ABCG1 mediates the efflux of cholesterol and phosphatidylcholine, especially sphingomyelin, onto HDL [23, 24] . Caveolae, a specialized type of lipid rafts, is comprised of cholesterol and caveolin (Cav) proteins [25] . Cav-1, the major protein of caveolae, interacts with cholesterol and plays an important role in maintaining membrane microdomain stability [26] .
The aim of this study was to investigate how HDL promotes osteoclast cholesterol efflux and its effect on osteoclast formation and survival. We found that HDL promotes osteoclast cholesterol efflux by upregulating ABCG1 expression, which disrupts cholesterol homeostasis in osteoclasts and consequently induces osteoclast apoptosis and affects its formation.
Materials and Methods
Cell culture and treatment RAW264.7 mouse macrophage cell line was obtained from the Cell Bank of Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences (Shanghai, China). RAW264.7 cells were used as osteoclast precursor cells and maintained in a modified essential medium (Sigma, St Louis, USA) supplemented with 10% fetal bovine serum (FBS) at 37°C and 5% CO 2 . For osteoclast induction, RAW264.7 cells were seeded in a 96-well plate at a density of 4 × 10 3 cells/well and stimulated with 100 ng/ml RANKL (ab129136; Abcam, Cambridge, USA) and 100 ng/ml M-CSF (ab217416; Abcam) for 4 days.
siRNA transfection
RAW264.7 cells were seeded into a 6-well plate in 2.3 ml medium containing 10% FBS and stimulated with 100 ng/ml RANKL and 100 ng/ml M-CSF. Thereafter, cells were transfected with ABCG1 siRNA (5′-TCGTATCTTATCTGTAGAGAA-3′) or control siRNA (5′-AAUUCUCCGAACGUGUCACGUGAGA-3′) (Dharmacon, Shanghai, China) using Lipofectamine 2000 (Invitrogen, Shanghai, China) for 48 h following the manufacturer's protocol. After transfection, the cells were cultured for 48 h at 37°C in a 5% CO 2 atmosphere for further experiments.
Protein extraction and western blot analysis
Total proteins were extracted from RAW264.7 cells and osteoclasts as previously described [27] . Same amounts of total proteins (20 μg each) were subject to 6% SDS-PAGE, followed by electrotransfer to polyvinylidene fluoride (PVDF) membranes (Millipore, Boston, USA). The membranes were blocked with 5% milk in Tris-buffered saline with Tween 20 (TBST) for 4 h at room temperature and then incubated with respective primary antibodies at 4°C with gentle shaking overnight. Mouse anti-ABCG1 (ab52617, 1:5000 dilution), anti-β-actin (ab8226, 1:5000 dilution), and anti-caveolin-1 (ab2910, 1:5000 dilution) antibodies in 5% evaporated milk were purchased from Abcam. The membranes were then washed three times (10 min each time) with TBST, followed by incubation with HRP-conjugated secondary antibody (1:5000 dilution; Proteintech, Chicago, USA) for 4 h at room temperature. After wash with TBST, the protein bands were visualized using an enhanced chemiluminescence plus western blotting detection system (Amersham Biosciences, Shanghai, China).
Real-time quantitative polymerase chain reaction analysis
Real-time quantitative polymerase chain reaction (RT-qPCR) analysis was performed as previously described [28] . Total RNA was extracted from RAW264.7 cells using TRIzol reagent (Qiagen, Valencia, Germany) according to manufacturer's instructions. cDNA fragments (2 μg) were obtained using a reverse transcription kit (Thermo Fisher Scientific, Shanghai, China). Quantitative PCR was conducted with the Light Cycler Run 5.32 Real-Time PCR System (Roche, Beijing, China) utilizing SYBR Green Master Mix (Applied Biosystems, Foster City, USA). A single DNA duplex was produced with Melt curve analyses. PCR primer sequences were as follows: ABCG1 sense 5′-GGTGGTCTCGCTGATGAAAG-3′ and anti-sense 5′-CTGCTGGGTTGTGGTAGGTT-3′; Cav-1 sense 5′-TATGACGCGCACACCAAGGA-3′ and anti-sense 5′-GCCCAGAT GTGCAGGAAGGA-3′; β-actin sense 5′-ATCGTGCGTGACATT AAGGAGAAG-3′ and anti-sense 5′-AGGAAGGAAGGCTGGAAG AGTG-3′. The amplification efficiency was similar for each gene. The total products were evaluated by melt curve analyses, in which DNA duplexes were confirmed. Measurements were quantified using the method of ΔΔC t and β-actin was used as the internal control.
Tartrate-resistant acid phosphatase histochemistry
Osteoclast differentiation was assessed by tartrate-resistant acid phosphatase (TRAP) staining as described previously [29] . In brief, rehydrated specimens were mixed with 0.2 ml of acetate buffer (sodium acetate and sodium tartrate dibasic dehydrate) at the room temperature for 20 min. Napthol ASMX phosphate and fast red TR salt (GeneTex, Irvine, USA) were added, followed by incubation at 37°C for 1 h with close monitoring under the microscope (BX51; Olympus, Tokyo, Japan) after the first half an hour for bright red staining of osteoclastic activity. Right red staining of the TRAP + osteoclasts was closely monitored under the microscope. Stained sections were washed in deionized water, counterstained with Gill's hematoxylin (Seebio, Shanghai, China), and then analyzed using the microscope.
Cholesterol efflux assay RAW264.7 cells were cultured and differentiated as described above and then radiolabeled with 5Ci/mmol [ 3 H]cholesterol (Sigma, St Louis, USA) for 2 h. After being washed twice with phosphatebuffered saline (PBS), the cells were cultured in RPMI 1640 medium Figure 1 . Effect of HDL on osteoclasts (A) TRAP-positive multinucleated cells analysis. RAW264.7 cells were cultured as osteoclast precursors and treated with both RANKL (100 ng/ml) and M-CSF (100 ng/ml) for differentiation and fusion. The cells were supplied with medium only (the control group) or medium containing HDL (600 ng/ml, the treated group). TRAP staining was performed on Days 1, 2, 3, 4, 5, and 6. The number of TRAP-positive multinucleated cells was determined under a microscope. Cells with the nuclei larger than or equal to three were counted as osteoclasts. (B) Maximum diameter analysis. TRAP-positive staining was performed on Day 3 and Day 4 after treatment. Forty osteoclasts were randomly selected for the measurement of the maximum diameter. (C) Fusion index that was calculated as the ratio of total numbers of nuclear to total multinucleated osteoclast numbers. (D) Pyknotic nuclei were observed by microscopy. (E) Apoptotic rate analysis. The apoptotic rate of cells in response to HDL was measured at Days 1, 2, 3 and 4 using a microplate reader-based apoptosis detection kit. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. control, **P < 0.01 vs. control. In A-D: left column, control; right column, HDL group.
(Sigma) supplemented with human ApoAI (600 ng/ml; Sigma), preβ-HDL (600 ng/ml; Sigma), HDL2 (600 ng/ml; Sigma), or HDL3 (600 ng/ml; Sigma) as lipid acceptors. And 1 day later, the radioactivities in cells and media were measured with a liquid scintillation counter (Taize Radar Company, Beijing, China) separately. The percent of efflux was quantified according to the following equation: [total media counts/(total media counts + total cellular counts)] × 100%.
High-performance liquid chromatography assay
Lipid analysis in the RAW246.7 cells was conducted by highperformance liquid chromatography (HPLC) as described previously [30] . In brief, cells were detached using trypsin (Beyotime Biotechnology, Shanghai, China) and 1% EDTA in PBS (T4174; Sigma) for collection. The sterol analysis was performed using the HPLC system (Model 2790, controlled with Empower Pro software; Waters Corp., Milford, USA). Sterols were detected using a photodiode array detector equipped with a 4-lL cell (Model 996; Waters Corp). The levels of cholesterol were determined by measuring the absorbance at 210 nm following elution with acetonitrile-isopropanol (30:70, v/v). Total Chrom software from PerkinElmer (Shanghai, China) was used for the analysis of all data.
Cell apoptosis assay
Cells were seeded in 96-well culture plates at the density of 9 × 10 4 cells/well and then treated with 200, 400, 600, and 800 ng/ml HDL (Sigma). Cell apoptosis was measured at 0, 1, 2, 3, and 4 days postreoxygenation with a microplate reader-based Titer TACS in situ apoptosis detection kit (4822-96-K; R&D Systems, Minneapolis, USA) according to manufacturer's protocol. Each experiment was performed in duplicate and repeated three times.
Nuclear pyknosis assessment
The cells were treated with HDL, RANKL, and M-CSF. TRAP staining was applied to assess osteoclast differentiation when cells were cultured for 3 and 4 days, and then TRAP + multinucleated osteoclast nuclear pyknosis was observed using the microscope.
Statistical analysis
Data were presented as the mean ± SD obtained from at least three independent experiments. Statistical analyses were performed using unpaired Student's t-test. P < 0.05 indicates significant difference. Statistic analysis was done with SPSS 18.0 software.
Results

HDL affects osteoclast formation and induces apoptosis
To explore the effects of HDL on osteoclasts, we used RANKL (100 ng/ml) and M-CSF (100 ng/ml) to induce the differentiation of RAW264.7 cells into multinucleated osteoclasts. Osteoclast differentiation was assessed by TRAP staining. As shown in Fig. 1A , TRAPpositive multinucleated osteoclasts started to appear at Day 2 of treatment and reach the peak at Day 4. HDL significantly reduced the number of differentiated cells (Fig. 1A) . Next, we investigated the underlying mechanism for HDL's action on osteoclast differentiation. Totally, 40 multinucleated osteoclasts from 3 or 4 days were randomly selected for measuring their maximum diameters. It was found that the maximum diameter of the cells (Fig. 1B) and the fusion index (Fig. 1C) were reduced in the HDL-treated group when compared to the control group. Preosteoclast cells fuse with each other to form osteoclasts. During this process, the number of Figure 2 . Effect of HDL on cholesterol efflux (A,B) Cholesterol efflux analysis. Cells were cultured with 200, 400, 600, and 800 ng/ml HDL for 3 days (A) and with 600 ng/ml HDL for 1, 2, 3, and 4 days (B). Cholesterol efflux was then detected using a liquid scintillation counter. (C,D) Cellular free cholesterol in RAW264.7 cells and cholesterol efflux. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. control, **P < 0.01 vs. control. multinucleated cells is increased; the nucleus is then increased and becomes mature gradually. The maximum diameter and the fusion index that reflect osteoclast formation are also increased. Thus, HDL treatment decreased osteoclast formation. Data obtained from the nuclear pyknosis experiment revealed that HDL promoted osteoclast apoptosis (Fig. 1D) . To confirm these findings, we incubated the cells with 600 ng/ml HDL and tested cell apoptosis at different days post-treatment using a commercial kit. It was found that HDL treatment markedly increased cell apoptosis (Fig. 1E) . These data indicated that the maximum diameter and fusion index of osteoclasts were decreased, while the ratios of osteoclasts with pyknotic nuclei were increased when cells were treated with HDL.
HDL promotes osteoclast cholesterol efflux
Considering the very low ability to synthesize cholesterol, osteoclasts rely on external sources to maintain cellular cholesterol homeostasis during their differentiation. Therefore, we performed a cholesterol efflux assay and found that HDL promoted osteoclast cholesterol efflux in both concentration-and time-dependent manners ( Fig. 2A,B) . We further examined cholesterol content in RAW264.7 cells using HPLC. The results from this experiment showed that the intracellular free cholesterol level was significantly lower in the HDLtreated RAW264.7 cells than that in the control group (Fig. 2C) . On the other hand, HDL had no significant effect on cholesterol efflux from RAW264.7 cells (Fig. 2D) . Taken together, our findings demonstrated that HDL promoted osteoclast cholesterol efflux and consequently reduced cellular cholesterol content in osteoclasts.
Effects of HDL subfractions on osteoclast formation and apoptosis
Next, we explored the roles of HDL subtypes in the formation and apoptosis of osteoclasts. Osteoclasts were incubated with [
3 H]cholesterol and ApoAI, HDL2, HDL3, or preβ-HDL. As shown in Fig. 3A , HDL2 had no detectable effect on cholesterol efflux from osteoclasts, while all the other subtypes of HDL tested significantly , and pyknotic nuclei analysis. RAW264.7 cells were treated with 600 ng/ml HDL3 and HDL2 with RANKL and M-CSF. After 3 days, multinucleated osteoclast, fusion index, and pyknotic nuclei were examined under a microscope. (E) Apoptotic rate analysis. The apoptotic rate of cells in response to HDL2 and HDL3 was measured at Day 4 using a microplate reader-based apoptosis detection kit. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. control, **P < 0.01 vs. control.
increased cholesterol efflux with the acceptor efficiency as follows: HDL3>preβ-HDL>ApoAI>HDL2, indicating that the ability of HDL3 to stimulate cholesterol efflux was stronger than preβ-HDL, HDL2, and ApoAI. And 3 days later, the TRAP-positive multinucleated osteoclasts, fusion index, and nuclear pyknosis were measured. HDL3 but not HDL2 significantly reduced the number of multinucleated osteoclasts and fusion index but increased nuclear pyknosis (Fig. 3B-D) . Furthermore, we examined the effect of HDL subfractions on osteoclast apoptosis using a commercial kit and found that HDL3, but not HDL2, significantly increased cell apoptosis (Fig. 3E) . Therefore, the effects of HDL on osteoclast formation and apoptosis may be mainly associated with the ability of HDL3 to mediate cholesterol efflux from osteoclasts.
HDL3 promotes the expression of osteoclast ABCG1
Here, we found that the efficiency of HDL3-mediated cholesterol efflux from osteoclasts was much stronger than that of AopAI (Fig. 3A) . Therefore, we hypothesized that HDL3 might promote osteoclast cholesterol efflux in an ABCG1-dependent manner. To test this hypothesis, the levels of ABCG1 mRNA and protein were detected. As shown in Fig. 4A -C, the mRNA and protein levels of ABCG1 were significantly increased in a concentration-dependent manner after incubation with HDL3 for 3 days. Data obtained from the time course experiments showed that the differences in ABCG1 expression reached statistical significance at the 3-and 4-day incubation with HDL3 (Fig. 4D-F) . To further confirm these findings, we treated RAW264.7 cells with RANKL and M-CSF that are key osteoclasogenic factors and found that RANKL dramatically reduced ABCG1 expression, and 3 days of treatment with 600 ng/ml HDL3 restored the reduction in ABCG1 expression induced by RANKL (Fig. 4G-I) . Next, we used siRNA to knock down ABCG1 expression in RAW264.7 cells treated with 600 ng/ml HDL3 for 3 days. As shown in (Fig. 4J) , knockdown of ABCG1 significantly reduced HDL3-mediated cholesterol efflux and suppressed HDL3-induced reduction in osteoclast formation. These results indicated the requirement of ABCG1 for the effects of HDL3 on osteoclasts. Cells were cultured with 200, 400, 600, and 800 ng/ml HDL3 for 3 days (A-C), or with 600 ng/ml HDL3 for 1, 2, 3, and 4 days (D-F). Relative protein levels were measured by western blot analysis, and mRNA levels were quantified by qRT-PCR. (G-I) The RAW246.7 cells were treated with RANKL and then incubated in medium with or without 600 ng/ml HDL3 for 3 days. Whole-cell lysates were subjected to western blot analysis. Relative protein levels were measured by densitometric analysis and mRNA levels were measured by qRT-PCR. (J) Effect of HDL3 on the formation of osteoclasts when the cells were transfected with ABCG1 siRNA. Cells were transfected with HDL3 or HDL3+siABCG1 for 3 days. The cholesterol efflux was detected using a liquid scintillation counter. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. control, # P < 0.01 vs. RANKL.
Effect of HDL3 on cell membrane of osteoclasts
Given that ABCG1 can mediate efflux of cholesterol and phospholipids, we tested if ABCG1 promotes phospholipid efflux from osteoclasts. RAW264.7 cells were treated with RANKL and M-CSF to promote osteoclast formation in the presence or absence of HDL3 (600 ng/ml). As shown in Fig. 5A , HDL3 significantly enhanced sphingomyelin efflux from osteoclasts. Furthermore, HDL3 reduced Cav-1 expression at both mRNA and protein levels (Fig. 5B-D) . These data indicated that HDL3 promotes sphingomyelin efflux through reducing Cav-1 expression, leading to osteoclast apoptosis.
Discussion
A large number of clinical studies have shown that dyslipidemia is strongly associated with osteoporosis [31] . Indeed, lipid disorders can lead to the development of pathological bone conditions systemically and/or locally [32] . The molecular mechanisms underlying the association between bone formation and lipid metabolism, however, are not fully understood. Here, we found that HDL promotes the outflow of cholesterol and phospholipid from osteoclasts through the upregulation of ABCG1 expression, which results in lipid raft dysfunction and subsequently enhances osteoclast apoptosis and impairs the formation of osteoclasts.
Cholesterol is an essential structural component of mammalian cell membranes and plays a crucial role in normal embryonic development, cell differentiation, nerve conduction, membrane fluidity and steroid synthesis [33] . The caveolae, a plasma membrane invaginations of lipid rafts enriched in cholesterol and sphingolipids, have diverse functions including endocytosis, transcytosis, intracellular cholesterol, and regulation of various signaling events [34] . Previous studies have shown that the lack of exogenous LDL leads to osteoclast intracellular cholesterol imbalance, thus affecting the transcription factor T-cell nuclear factor 1 (NFATc1) activation and impairing the osteoclast formation [35] [36] [37] . Notably, clinical data have suggested the concept that statins, the cholesterol-lowering drugs, may decrease the risk of bone fracture [38] . Moreover, LDLR-deficient osteoclasts that have lower levels of cellular cholesterol than that in wild-type cells display a reduction in size and lifespan [36] . Thus, cellular cholesterol levels are closely related to osteoclast formation. Here, we treated cultured osteoclast cells with HDL and found that HDL enhanced cholesterol efflux and apoptosis.
HDL is a vital constituent of the lipoprotein transport system and regulates plasma and tissue lipid metabolism and homeostasis [39] . HDL is a heterogeneous population of lipoprotein particles, such as preβ-HDL, HDL3, and HDL2 that have distinct sizes, shapes, and compositions of proteins and lipids [40] . Human arterial smooth muscle cells express ABCA1 that participates in the RCT pathway. RCT allows lipid-laden cells to export excessive cellular lipids to carriers for the transport to the liver [41] . ABCA1 is known to mediate cholesterol efflux mainly to lipid-free or poorly lipidated ApoA-I to form preβ-HDL. On the other hand, ABCG1 mainly mediates cholesterol efflux to lipidated ApoAI and HDL [24] . In the present study, we found that the efficiency of HDL3 on mediating cholesterol efflux from osteoclasts and induce apoptosis of osteoclasts was much higher than that of AopA1. It has been reported that HDL3 is the most efficient receptor for ABCG1-mediated cholesterol efflux when compared to HDL2 and preβ-HDL [42] . Thus, our findings indicate the main contribution of ABCG1 to the HDL's action on osteoclast formation. Indeed, HDL3 increased, but the osteogenic factor RANKL reduced ABCG1 expression. Furthermore, HDL3 suppressed the inhibitory effect of RANKL on ABCG1 expression. Knockdown of ABCG1 essentially eliminated the effects of HDL3 on cholesterol efflux from osteoclasts and osteoclast formation. In addition, we found that HDL3 increased phospholipid efflux from osteoclasts and reduced Cav-1 expression. It has been reported that Cav-1 directly interacts with ABCG1 and regulates Figure 5 . HDL3 reduces the expression of Cav-1 (A) RAW264.7 cells were treated with 600 ng/ml HDL3 with the addition of RANKL for 3 days. Sphingomyelin efflux was checked using a liquid scintillation counter. (B-D) Relative protein levels were measured by western blot analysis, and mRNA levels were measured by qRT-PCR. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. control, **P < 0.01 vs. control.
ABCG1-mediated cholesterol efflux [43] . Taken together, these findings suggest that HDL increases ABCG1 expression, promotes cholesterol and phospholipid efflux, and reduces Cav-1 expression in osteoclasts, which leads to imbalanced cellular cholesterol and disrupted lipid rafts in osteoclasts. This may induce apoptosis of osteoclasts and impair osteoclast formation. However, the mechanisms for HDL-induced upregulation of ABCG1 expression and downregulation of Cav-1 expression remain unclear and need to be further studied. In addition, we observed that ApoAI and preβ-HDL mediated cholesterol efflux but to a less extent than HDL3. ApoA-I mainly mediates ABCA1-dependent cholesterol efflux, which has been intensively studied in macrophages [22] .
Given that HDL is well known to prevent the development of atherosclerosis, our study provides new evidence for the correlation between osteoporosis and atherosclerosis and suggests a new idea for the common prevention and treatment of both osteoporosis and atherosclerosis.
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